BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5316913)

  • 1. A biological standard for measurement of blood coagulation Factor VIII activity.
    Bangham DR; Biggs R; Brozović M; Denson KW; Skegg JL
    Bull World Health Organ; 1971; 45(3):337-51. PubMed ID: 5316913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of Factor VIII-III. Establishment of a stable reference plasma for Factor VIII-related activities.
    Barrowcliffe TW; Tydeman MS; Kirkwood TB; Thomas DP
    Thromb Haemost; 1983 Oct; 50(3):690-6. PubMed ID: 6417818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of Factor VIII-IV. Establishment of the 3rd International Standard for Factor VIII: C concentrate.
    Barrowcliffe TW; Curtis AD; Thomas DP
    Thromb Haemost; 1983 Oct; 50(3):697-702. PubMed ID: 6417819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of a proposed international standard for blood coagulation factor IX.
    Brozović M; Kirkwood TB; Robertson I
    Thromb Haemost; 1976 Feb; 35(1):222-36. PubMed ID: 989189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A collaborative study to establish a Korean Standard for factor VIII:C concentrate.
    Kang HN; Kim SN; Lee SH; Hong SH
    Thromb Res; 2004; 113(3-4):261-7. PubMed ID: 15140591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
    Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of protein C in plasma: establishment of an international standard.
    Hubbard AR
    Thromb Haemost; 1988 Jun; 59(3):464-7. PubMed ID: 3187933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.
    Barrowcliffe TW; Raut S; Sands D; Hubbard AR
    Semin Thromb Hemost; 2002 Jun; 28(3):247-56. PubMed ID: 12098084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma.
    Heath AB; Barrowcliffe TW
    Thromb Haemost; 1992 Aug; 68(2):155-9. PubMed ID: 1412160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent.
    Mazurier C; Parquet-Gernez A; Goudemand M
    Thromb Haemost; 1990 Oct; 64(2):251-5. PubMed ID: 2125374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international collaborative study establishing a reference preparation for Antithrombin III.
    Kirkwood TB; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1980 Feb; 43(1):10-5. PubMed ID: 7404474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative study on assays of activated FIX (FIXa). On behalf of the factor VIII and factor IX subcommittee of the ISTH. International Society on Thrombosis and Haemostasis.
    Gray E; Walker D; Heath A; Barrowcliffe TW
    Thromb Haemost; 1996 Dec; 76(6):1114-7. PubMed ID: 8972040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International reference standards in coagulation.
    Raut S; Hubbard AR
    Biologicals; 2010 Jul; 38(4):423-9. PubMed ID: 20338786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international collaborative assay of factor VIII clotting activity.
    Barrowcliffe TW; Kirkwood TB
    Thromb Haemost; 1978 Oct; 40(2):260-71. PubMed ID: 734631
    [No Abstract]   [Full Text] [Related]  

  • 16. Analytic variability due to change of deficient plasma vials: application to one-stage clotting factor VIII assay.
    Nougier C; Sobas F; Nguyen TK; Carage ML; Lienhart A; Négrier C
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):151-4. PubMed ID: 21192255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calibration of the Ph. Eur. human coagulation Factor VIII concentrate BRP batch 5.
    Raut S; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2017; 2017():1-11. PubMed ID: 28279252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
    Kessler CM; Bernstein Z; Ghesani S; Shamsipour Z; Frances C; Zucker ML; LaDuca FM
    Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.